Mr. Jonathan Nugent

Biography

 Mr. Jonathan Nugent is a member of Agenta's Board of Advisors.  John has significant experience in financial matters pertaining to biotechnology, most recently as Vice President, Corporate Communications and Investor Relations of the Birmingham-based public company BioCryst.  Prior to joining BioCryst, Mr. Nugent served as Senior Vice President and Director of Investor Relations at Burns McClellan, Inc., the country's largest independent healthcare public and investor relations firm. Working primarily in the agency's New York office, Mr. Nugent provided senior counsel to companies specializing in pharmaceutical discovery and development, drug delivery, medical devices and diagnostics, as well as to advisory and investment firms focusing on the biotechnology industry. He has extensive experience in providing strategic guidance in the areas of financial, scientific and regulatory communications, product launches, meetings before the FDA, IPO and follow-on financings, U.S. and European investors and crisis and issues management. John understands corporate financing as it pertains to biotechnology and adds value to Agenta through his advice as well as his relationships with others in the biotechnology and financing industries.

Research Interest

 Bio technology